A detailed history of Hrt Financial LP transactions in Io Biotech, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 12,689 shares of IOBT stock, worth $10,912. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,689
Previous 26,646 52.38%
Holding current value
$10,912
Previous $27,000 59.26%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$0.68 - $1.33 $9,490 - $18,562
-13,957 Reduced 52.38%
12,689 $11,000
Q3 2024

Nov 12, 2024

BUY
$0.75 - $1.64 $19,984 - $43,699
26,646 New
26,646 $27,000

Others Institutions Holding IOBT

About IO Biotech, Inc.


  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $24.8M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.